To establish whether the upregulation of TARBP2 in tamoxifen-resistant breast cancer cells could be observed in human tumors, we collected metastatic tumors and their corresponding primary tumors from breast cancer patients receiving hormone therapy and analyzed TARBP2 expression in these tissues by IHC (Figure 1C,D). Here, TARBP2 is linked to breast carcinoma.